263 related articles for article (PubMed ID: 34571286)
1. The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
Kim H; Park JT; Lee J; Jung JY; Lee KB; Kim YH; Yoo TH; Kang SW; Choi KH; Oh KH; Ahn C; Han SH;
Atherosclerosis; 2021 Oct; 335():53-61. PubMed ID: 34571286
[TBL] [Abstract][Full Text] [Related]
2. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
[TBL] [Abstract][Full Text] [Related]
3. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
4. Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank.
Heo GY; Koh HB; Jung CY; Park JT; Han SH; Yoo TH; Kang SW; Kim HW
Am J Kidney Dis; 2024 Jun; 83(6):729-738.e1. PubMed ID: 38171411
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
[TBL] [Abstract][Full Text] [Related]
7. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
[TBL] [Abstract][Full Text] [Related]
8. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
[TBL] [Abstract][Full Text] [Related]
9. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
10. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
[TBL] [Abstract][Full Text] [Related]
11. The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.
Zhang LW; Luo MQ; Zeng JL; You ZB; Chen LC; Chen JH; Lin KY; Guo YS
Clin Interv Aging; 2024; 19():411-420. PubMed ID: 38476830
[TBL] [Abstract][Full Text] [Related]
12. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
Wang Y; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS; Inker LA
Kidney Med; 2023 Oct; 5(10):100710. PubMed ID: 37753251
[TBL] [Abstract][Full Text] [Related]
13. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
[TBL] [Abstract][Full Text] [Related]
14. Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline.
Li C; Ma Y; Yang C; Hua R; Xie W; Zhang L
JAMA Netw Open; 2022 Sep; 5(9):e2234208. PubMed ID: 36178684
[TBL] [Abstract][Full Text] [Related]
15. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C for kidney function assessment in patients with facioscapulohumeral muscular dystrophy.
Mondesert E; Bargnoux AS; Portet F; Laoudj-Chenivesse D; Arbogast S; Badiou S; Brun JF; Kuster N; de Mauverger ER; Cristol JP
Clin Chim Acta; 2023 Apr; 544():117328. PubMed ID: 37031784
[TBL] [Abstract][Full Text] [Related]
17. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
[TBL] [Abstract][Full Text] [Related]
19. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
Zhang LW; Luo MQ; Xie XW; You ZB; Zeng JL; Lin MQ; Chen LC; Lin KY; Guo YS
J Am Heart Assoc; 2023 Jan; 12(1):e027980. PubMed ID: 36565177
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study.
Potok OA; Ix JH; Shlipak MG; Bansal N; Katz R; Kritchevsky SB; Rifkin DE
Kidney Med; 2022 Mar; 4(3):100416. PubMed ID: 35386603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
